Literature DB >> 22389078

Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine.

Ornella Corazza1, Fabrizio Schifano, Pierluigi Simonato, Suzanne Fergus, Sulaf Assi, Jacqueline Stair, John Corkery, Giuseppina Trincas, Paolo Deluca, Zoe Davey, Ursula Blaszko, Zsolt Demetrovics, Jacek Moskalewicz, Aurora Enea, Giuditta di Melchiorre, Barbara Mervo, Lucia di Furia, Magi Farre, Liv Flesland, Manuela Pasinetti, Cinzia Pezzolesi, Agnieszka Pisarska, Harry Shapiro, Holger Siemann, Arvid Skutle, Aurora Enea, Giuditta di Melchiorre, Elias Sferrazza, Marta Torrens, Peer van der Kreeft, Daniela Zummo, Norbert Scherbaum.   

Abstract

On the basis of the material available both in the scientific literature and on the web, this paper aims to provide a pharmacological, chemical and behavioural overview of the novel compound methoxetamine. This is a dissociative drug related to ketamine, with a much longer duration of action and intensity of effects. A critical discussion of the availability of information on the web of methoxetamine as a new recreational trend is here provided. Those methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, are here discussed as well. It is concluded that the online availability of information on novel psychoactive drugs, such as methoxethanine, may constitute a pressing public health challenge. Better international collaboration levels and novel forms of intervention are necessary to tackle this fast-growing phenomenon.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22389078     DOI: 10.1002/hup.1242

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  17 in total

1.  Recreational drugs of abuse.

Authors:  Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

2.  The availability and depiction of synthetic cathinones (bath salts) on the Internet: Do online suppliers employ features to maximize purchases?

Authors:  Kathleen Meyers; Övgü Kaynak; Elena Bresani; Brenda Curtis; Ashley McNamara; Kristine Brownfield; Kimberly C Kirby
Journal:  Int J Drug Policy       Date:  2015-01-16

3.  Novel psychoactive substances of interest for psychiatry.

Authors:  Fabrizio Schifano; Laura Orsolini; G Duccio Papanti; John M Corkery
Journal:  World Psychiatry       Date:  2015-02       Impact factor: 49.548

4.  Neurochemical profiles of some novel psychoactive substances.

Authors:  Les Iversen; Simon Gibbons; Ric Treble; Vincent Setola; Xi-Ping Huang; Bryan L Roth
Journal:  Eur J Pharmacol       Date:  2012-12-21       Impact factor: 4.432

5.  The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents.

Authors:  Adam L Halberstadt; Natalia Slepak; James Hyun; Mahalah R Buell; Susan B Powell
Journal:  Psychopharmacology (Berl)       Date:  2016-01-13       Impact factor: 4.530

6.  Fatalities associated with NPS stimulants in the Greater Cologne area.

Authors:  Sabrina Lehmann; Tobias Kieliba; Mario Thevis; Markus A Rothschild; Katja Mercer-Chalmers-Bender
Journal:  Int J Legal Med       Date:  2019-11-18       Impact factor: 2.686

7.  Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances.

Authors:  Elena Deligianni; Omari J Daniel; John M Corkery; Fabrizio Schifano; Lisa A Lione
Journal:  Br J Clin Pharmacol       Date:  2020-01-09       Impact factor: 4.335

8.  Phencyclidine-like in vivo effects of methoxetamine in mice and rats.

Authors:  Michael D Berquist; William S Hyatt; Jonathan Bauer-Erickson; Brenda M Gannon; Andrew P Norwood; William E Fantegrossi
Journal:  Neuropharmacology       Date:  2017-08-19       Impact factor: 5.250

9.  The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission.

Authors:  Anna Mutti; Sonia Aroni; Paola Fadda; Laura Padovani; Laura Mancini; Roberto Collu; Anna Lisa Muntoni; Liana Fattore; Cristiano Chiamulera
Journal:  Psychopharmacology (Berl)       Date:  2016-03-28       Impact factor: 4.530

10.  The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor.

Authors:  Bryan L Roth; Simon Gibbons; Warunya Arunotayanun; Xi-Ping Huang; Vincent Setola; Ric Treble; Les Iversen
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.